Abbott Laboratories (ABT) is facing a retrial of a case, alleging its formula milk was harmful to infants, on grounds of prejudiced or erroneous rulings in a state court in Missouri last year.
A jury last October handed a unanimous verdict siding with Abbott, Mead Johnson, Mead Johnson
Nutrition and St. Louis Children's Hospital after hearing a lawsuit brought by the family of a preterm infant who developed problems after being fed formula made by the companies.
The plaintiffs sought to have the case retried, contending counsel for the companies made multiple misleading statements throughout the trial, including allegations that the mother smoked tobacco and marijuana during pregnancy rather than the formula that developed necrotizing enterocolitis.
The court approved a minor settlement between the defendant and the hospital. Case against Abbott and Mead, however, will proceed to a trial.
"The court finds the errors and misconduct were so prejudicial that affected the credibility of evidence with extreme passion and bias that denied plaintiff a fair trial and undermined the entire judicial process," Missouri Circuit Court Judge Michael W. Noble said in his March 13 decision.
Abbott Labs did not immediately reply to a message from MT Newswires seeking comment.
Price: 126.43, Change: -3.46, Percent Change: -2.66
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。